What is LIBTAYO?

Locally advanced BCC can be treated with immunotherapy

Cannot be removed by surgery (locally advanced BCC) and have received treatment with a hedgehog inhibitor (HHI), or cannot receive treatment with an HHI

LIBTAYO is a type of immunotherapy—not chemotherapy or radiation therapy.

LIBTAYO is a prescription medicine used to treat people with a type of skin cancer called BCC that:

I was taking an HHI. Now what?

Some patients who may have tried an HHI cannot stay on treatment because it stops working and their tumors grow again, or they have side effects from taking the drug.

For people who have tried an HHI, LIBTAYO could be the next treatment option prescribed by your doctor for locally advanced BCC.

LIBTAYO and HHIs are both systemic therapies, which are drugs that move through the body to treat locally advanced BCC. Systemic therapies include treatments like chemotherapy, targeted drugs (for example, HHIs), and immunotherapy (for example, LIBTAYO).

LIBTAYO is an immunotherapy given through an infusion that may help your immune system recognize, attack, and kill the cancer cells. Your body might not attack cancer because the cancer cells have developed ways to avoid the immune system. This treatment is given by an oncologist.

Immunotherapy can cause your immune system to attack normal organs and tissues in your body, which may cause serious side effects.

LIBTAYO works with your immune system to help treat locally advanced BCC.